Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on adjuvant therapy

Creutzberg, C. L., Leon-Castillo, A., de Boer, S. M., Powell, M. E., Mileshkin, L. R., Mackay, H. J., Leary, A., Nijman, H. W., Singh, N., Pollock, P., Fyles, A., Haie-Meder, C., Smit, V. T. H. B. M., Edmondson, R. J., Putter, H., Kitchener, H. C., Crosbie, E. J., de Bruyn, M., Nout, R. & Bosse, T., okt.-2019, In: Annals of Oncology. 30, blz. 899-900 2 blz.

Onderzoeksoutput › Academic

PROGNOSTIC RELEVANCE OF THE MOLECULAR CLASSIFICATION IN HIGH-RISK ENDOMETRIAL CANCER: ANALYSIS OF THE PORTEC-3 TRIAL

Leon-Castillo, A., de Boer, S. M., Powell, M. E., Mileshkin, L. R., Mackay, H. J., Leary, A., Nijman, H. W., Singh, N., Pollock, P., Bessette, P., Haie-Meder, C., Smit, V. T. H. B. M., Edmondson, R. J., Putter, H., Kitchener, H. C., Crosbie, E. J., de Bruyn, M., Nout, R. A., Horeweg, N., Bosse, T., & 1 anderenCreutzberg, C. L., nov.-2019, In: International Journal of Gynecological Cancer. 29, blz. A7-A8 2 blz.

Onderzoeksoutput › Academic

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

PORTEC Study Grp, feb.-2018, In: Annals of Oncology. 29, 2, blz. 424-430 7 blz.

Onderzoeksoutput › Academic › peer review

Patterns of recurrence in the randomised PORTEC-3 trial of chemoradiotherapy for endometrial cancer

De Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., Colombo, A., Fyles, A., Baron, M. H., Jurgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Kolodziej, I., Carinelli, S., Lutgens, L. C. H. W., Smit, V. T. H. B. M., & 5 anderenSingh, N., Nout, R. A., Verhoeven-Adema, K. W., Putter, H. & Creutzberg, C. L., apr.-2018, In: Radiotherapy and Oncology. 127, blz. S171-S172 2 blz.

Onderzoeksoutput › Academic